Abbott Board Seeks To Nix Suit From Spinoff's Shareholders
By Jamie Santo · July 13, 2015, 10:31 PM EDT
Abbott Laboratories directors urged a Delaware Chancery judge Monday to toss a derivative suit that calls for them to bear defense costs for a whistleblower action faced by former subsidiary AbbVie...
To view the full article, register now.